DEUTSCHE BANK AG\
BankPosition in MDGL — Madrigal Pharmaceuticals, Inc.
CIK 948046
FRANKFURT AM MAIN, 2M
Position in MDGL
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$45,058,694
-$6,276,436 QoQ
Shares Held
83,916
-14.4% QoQ
Ownership
0.363%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#50
of 411 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. MDGL ranks #13 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in MDGL
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,058,694 | 83,916 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $51,335,130 | 98,067 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $111,872,752 | 192,109 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $17,127,280 | 37,342 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $7,298,162 | 24,115 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $8,592,105 | 25,940 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $13,471,548 | 43,658 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $10,386,470 | 48,942 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $13,047,330 | 46,571 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $12,429,642 | 46,546 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $13,743,276 | 59,397 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,406,919 | 43,871 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $8,554,161 | 37,031 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $14,336,945 | 59,180 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $17,956,896 | 61,867 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,343,734 | 51,450 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,534,046 | 49,372 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $4,874,403 | 49,678 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $2,999,708 | 35,399 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $1,663,220 | 20,845 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,960,569 | 20,127 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $14,524,864 | 124,176 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,181,820 | 19,626 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $2,075,637 | 17,482 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,967,943 | 17,377 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,038,643 | 75,474 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||